(IN BRIEF) SEAT S.A. has entered into a partnership with Hospital Clínic Barcelona, donating three SEAT Ibizas to support the mobility of professionals working in the hospital’s Home Care Area (HCA). The initiative aims to ensure safe and high-quality care … Read the full press release
(IN BRIEF) Merck, a prominent science and technology company, has entered into a collaboration with the United Nations’ Global Initiative on Ageing (GIA) to offer a training course aimed at equipping family carers with essential skills. The course comprises five … Read the full press release
Posted in Business, Education, Germany, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science
Tagged caregivers, Embracing Carers®, European Carers Day, Family Carers, Global Initiative on Ageing (GIA), Luis Gallegos, Merck, partnership, Peter Guenter, training course, United Nations
(IN BRIEF) Marks & Spencer (M&S) and YoungMinds, a leading youth mental health charity, have joined forces to address the mental health challenges faced by young people. A new partnership has been formed to raise awareness and funding for resources … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, Media, News, Non Profit, Science, United Kingdom
Tagged awareness, charity, funding, Laura Bunt, M&S, mental health issues, partnership, Victoria McKenzie-Gould, wellness, YoungMinds, YOUTH
(IN BRIEF) Roche has reported positive outcomes from the RAINBOWFISH study, an investigation into the efficacy and safety of Evrysdi® (risdiplam) in babies with pre-symptomatic spinal muscular atrophy (SMA). The study, which included 26 infants aged from birth to six … Read the full press release
Posted in Business, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland
Tagged Evrysdi, Levi Garraway, Pre-Symptomatic SMA Babies, RAINBOWFISH study, Richard Finkel, Roche, wellness
(IN BRIEF) Sanofi and Teva Pharmaceuticals have announced a collaboration to co-develop and co-commercialize TEV’574, a promising asset currently in Phase 2b clinical trials for the treatment of Ulcerative Colitis and Crohn’s Disease, both forms of inflammatory bowel disease (IBD). … Read the full press release
Posted in Business, Environment, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science
Tagged Anti-TL1As, Crohn's disease, in $1.5 Billion Deal, Inflammatory Bowel Disease Treatment, partnership, Paul Hudson, Richard Francis, Sanofi, sustainability, Teva, TEV’574, Ulcerative colitis, wellness
(IN BRIEF) Skanska has entered into an additional contract with RWJBarnabas Health to construct a new ambulatory care cancer center in Livingston, New Jersey, USA. The contract, valued at USD 85 million (approximately SEK 900 million), will be part of … Read the full press release
(IN BRIEF) A team led by Professor Robert Beardmore at the University of Exeter has won an Innovation Award at the Vivli Antimicrobial Resistance (AMR) Data Challenge for their work in harmonizing thresholds for antibiotic resistance using artificial intelligence (AI). … Read the full press release
Posted in Artificial Intelligence (AI), Awards, Business, Education, Healthcare, Management, News, Science, Technology, United Kingdom
Tagged AI-Driven, AMR Data Challenge, antibiotic resistance, Arjun Srinivasan, Australia, Awards, Dr Emily Wood, Professor Robert Beardmore, Spain, University of Exeter
(IN BRIEF) Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize a vaccine candidate for extraintestinal pathogenic E. coli (ExPEC) that is currently in Phase 3 of clinical trials. ExPEC … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science
Tagged E. coli, E.mbrace, ExPEC, Janssen, partnership, Sanofi, SEPSIS, sustainability, Thomas Triomphe, vaccine
(IN BRIEF) Leading global insurer AXA has unveiled its ‘We Care’ program, designed to bolster the well-being of its 110,000 employees in 51 countries. The initiative, a cornerstone of AXA’s strategic plan for 2024-2026, consists of four core pillars, including … Read the full press release
(IN BRIEF) The University of Oxford’s R21/Matrix-M™ malaria vaccine, developed in collaboration with the Serum Institute of India and leveraging Novavax’s adjuvant technology, has received a recommendation for use by the World Health Organization (WHO). After rigorous scientific review by … Read the full press release
Posted in Business, Education, Environment, Government, Healthcare, Industrial, Management, News, Non Profit, Pharma & Biotech, Science, United Kingdom
Tagged Adar Poonawalla, CHILDREN, Dr Lisa Stockdale, Dr Mehreen Datoo, John C. Jacobs, malaria vaccine, Novavax, partnership, Professor Sir Adrian Hill, R21/Matrix-M™, Serum Institute of India, sustainability, University of Oxford, World Health Organization
(IN BRIEF) Aviva and mixed-use developer Socius have been selected as the preferred bidders for the advancement of the London Cancer Hub (LCH), a world-leading district dedicated to cancer research and treatment in Sutton, London. The partnership will collaborate with … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Insurance, Investment, Management, News, United Kingdom
Tagged Aviva, Barry Jessup, bidders, Charlotte Jones, Cllr Ruth Dombey OBE, Dame Cally Palmer, Epsom & St Helier University Hospitals NHS Trust, Gillian Norton, Institute for Cancer Research, London Borough of Sutton, London Cancer Hub Development, partnership, Professor Paul Workman, Royal Marsden NHS Foundation Trust, Socius, sustainability
(IN BRIEF) The European Investment Bank (EIB) has signed a €10 million loan agreement with Polish company SDS Optic Inc. to support the development and commercialization of their innovative cancer detection technology platform, inPROBE®. SDS Optic specializes in diagnostic and … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Pharma & Biotech, Poland, Science, Technology
Tagged advanced photonic technologies, biomedical engineering, breast cancer, breast cancer detection device, cancer detection technology, diagnostics, EIB, immunochemistry, inPROBE®, inPROBE® HER2, InvestEU programme, loan, Marcin Staniszewski, Molecular Biology, monitoring devices, Paolo Gentiloni, photonic biosensing, Prof. Teresa Czerwińska, SDS Optic Inc., single cell resolution immunoassay, The European Investment Bank, Warsaw Stock Exchange
(IN BRIEF) Skanska has entered into an agreement with Region Värmland to construct a groundbreaking new reception building at the Central Hospital, CSK, located in Karlstad, Sweden. Valued at approximately SEK 740 million, this contract will be recorded as part … Read the full press release
(IN BRIEF) BASF Personal Care has introduced Epispot™, a sustainably sourced cosmetic ingredient designed to enhance the beauty and self-confidence of individuals with blemish-prone skin, a common issue affecting people worldwide regardless of gender, age, or ethnicity. Epispot addresses the … Read the full press release
(IN BRIEF) EQT, in collaboration with its co-shareholders, has agreed to sell LimaCorporate, a global orthopaedic implant manufacturer, to Enovis Corporation, a NYSE-listed company. LimaCorporate, known for its innovative orthopaedic solutions and additive manufacturing expertise, specializes in shoulder, knee, and … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Italy, Management, News, Real Estate, Sweden
Tagged acquisition, Enovis Corporation, EQT, Healthcare, LimaCorporate, Lualdi family, Massimo Calafiore, Matteo Thun, Orthopaedic Industry, partnership
(IN BRIEF) GSK plc has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) to prevent respiratory syncytial virus (RSV) disease in adults aged 60 and above. This marks … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Adults Aged 60 and Above, AReSVi-006, Arexvy, GSK, Japan, RSV Vaccine, Tony Wood, wellness
(IN BRIEF) Argentina’s Hospital Alemán in Buenos Aires embarks on a comprehensive expansion project known as the “Juncal” extension, aiming to provide top-notch medical services and modern infrastructure. Partnering with Lindner and KARL STORZ, the private hospital has added approximately … Read the full press release
(IN BRIEF) The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO, a novel factor VIII replacement therapy used to control bleeding in patients with hemophilia A. ALTUVIIIO, also known as efanesoctocog alfa, stands out … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science
Tagged ALTUVIIIO, authorization, bleeding, Brian Foard, efanesoctocog alfa, FDA, hemophilia A, Japan, marketing, MHLW, partnership, Sanofi, Sobi, treatment
(IN BRIEF) The British Safety Council has opened applications for the International Safety Awards 2024, marking the 66th year of these internationally recognized accolades for excellence in health, safety, and wellbeing. These awards honor organizations committed to maintaining high standards … Read the full press release
Posted in Awards, Business, Healthcare, Industrial, Management, Media, News, Non Profit, Security & Safety, Society, United Kingdom
Tagged applications, Awards, British Safety Council, health, International Safety Awards 2024, Mike Robinson, safety, wellbeing
(IN BRIEF) Novartis has announced successful results from its Phase III NETTER-2 trial involving Lutathera, a treatment for neuroendocrine tumors (NETs). When used as a first-line treatment in combination with long-acting octreotide, Lutathera significantly improved progression-free survival in patients with … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?